BenzingaOctober 22, 2026 at 11:20 AM NY5 Days Ago
Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $122
Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $125 to $122.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
